Wed, March 26, 2025
[ Wed, Mar 26th 2025 ]: Yahoo
4 seek Joplin School Board seats
Tue, March 25, 2025

Trump turbulence stalls large pharma and biotech deals, bankers say

Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets and set off a global trade war, according to four top healthcare investment bankers.
The article from Reuters discusses how the uncertainty surrounding former President Donald Trump's potential return to office is causing hesitation among pharmaceutical and biotech companies in pursuing large mergers and acquisitions. According to bankers, the fear stems from Trump's previous policies, including his criticism of high drug prices and threats to impose price controls, which could significantly impact the profitability and valuation of deals. This political uncertainty has led to a slowdown in deal-making, with companies and investors adopting a cautious approach, waiting to see the outcomes of the U.S. election before committing to major transactions. The article also notes that while there is still interest in smaller, strategic deals, the market for blockbuster mergers has cooled, with potential buyers and sellers wary of the regulatory and policy changes that might follow a Trump presidency.

Read the Full Reuters Article at:
[ https://www.reuters.com/business/healthcare-pharmaceuticals/trump-turbulence-stalls-large-pharma-biotech-deals-bankers-say-2025-03-26/ ]


Similar Business and Finance Publications